Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia.

Betel Del Rosario GarcíaMaría Micaela Viña RomeroVirginia González RosaCarolina Alarcón PayerLeonor Oliva OlivaFrancisco Javier Merino AlonsoGloria Julia Nazco CasariegoFernando Gutiérrez Nicolás

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

Adherence is one of the most relevant parameters affecting the effectiveness of highly effective chronic treatments. Approximately half of our patients showed inadequate adherence to treatment with TKIs, with employment status and the individual's level of education emerging as the determining factors.

Keyphrases

risk factors
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
randomized controlled trial
healthcare
systematic review
peritoneal dialysis
bone marrow
dendritic cells
immune response
metabolic syndrome
adipose tissue
skeletal muscle
weight loss
mental illness